328 results on '"Appelt, Ane"'
Search Results
2. Reirradiation − still navigating uncharted waters?
3. The role of medical physics experts in clinical trials: A guideline from the European Federation of Organisations for Medical Physics
4. Individual lymph node position variation for rectal cancer patients treated with long course chemoradiotherapy
5. Multi-centre evaluation of variation in cumulative dose assessment in reirradiation scenarios
6. Early radiologic and metabolic tumour response assessment during combined chemo-radiotherapy for locally advanced NSCLC
7. Treatment planning for patients with low rectal cancer in a multicenter prospective organ preservation study
8. Re-irradiation in clinical practice: Results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platform
9. Voxel-based analysis: Roadmap for clinical translation
10. Genetic Status Affects Disease-Specific Mortality But Not the Incidence of Local Recurrence in Patients with Uveal Melanoma
11. Treatment plan optimisation for reirradiation
12. Overall survival following heterogeneous FDG-guided dose-escalation for locally advanced NSCLC in the international phase III NARLAL2 trial.
13. Endorectal contact radiation boosting: Making the case for dose AND volume reporting
14. European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making
15. The role of medical physicists in clinical trials across Europe
16. Prognostic factors for patients with anal cancer treated with conformal radiotherapy—a systematic review
17. Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study
18. Survival benefits for non-small cell lung cancer patients treated with adaptive radiotherapy
19. GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer
20. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer
21. Efficacy of Dose-Escalated Chemoradiation on Complete Tumor Response in Patients with Locally Advanced Rectal Cancer (RECTAL-BOOST): A Phase 2 Randomized Controlled Trial
22. Outcome measures in multimodal rectal cancer trials
23. Patient reported upper gastro-intestinal symptoms associated with fractionated image-guided conformal radiotherapy for metastatic spinal cord compression
24. Mesorectal radiotherapy for early stage rectal cancer: A novel target volume
25. Long-Term Patient-Reported Outcomes After High-Dose Chemoradiation Therapy for Nonsurgical Management of Distal Rectal Cancer
26. Robust dose planning objectives for mesorectal radiotherapy of early stage rectal cancer – A multicentre dose planning study
27. Consistency in reirradiation scenarios: Terminology, tissue recovery in calculations, units and reporting
28. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis
29. Different benefits of adaptive radiotherapy for different histologies of NSCLC
30. Method for Automatic Selection of Parameters in Normal Tissue Complication Probability Modeling
31. Metal artefact reduction for accurate tumour delineation in radiotherapy
32. Phase 2 Neoadjuvant Treatment Intensification Trials in Rectal Cancer: A Systematic Review
33. 1294: A Multi-Omics Database Using Clinical Trial Data for Rectal Cancer Radiotherapy Outcome Prediction
34. 3531: The NARLAL II trial: First results on loco-regional control in stage 3 NSCLC
35. 2580: Best practices for a safe clinical workflow in the management of patients receiving reirradiation
36. 2509: Treatment planning for lung cancer re-irradiation accounting for previously delivered dose
37. 1741: Simultaneous integrated boost and organ at risk constraints in the APHRODITE trial [ISRCTN16158514]
38. 1299: Individualised isotoxic radiotherapy for re-irradiation in recurrent pelvic cancers
39. 965: Individualised dose mapping uncertainty estimation for head and neck cancer re-irradiation.
40. Brain Re-Irradiation Robustly Accounting for Previously Delivered Dose
41. Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study
42. Technical note: Optimization functions for re‐irradiation treatment planning.
43. Prognostic Value of Serum NPY Hypermethylation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Secondary Analysis of a Randomized Trial
44. Challenges of re-irradiation: A call to arms for physicists - and radiotherapy vendors
45. Re-irradiation in clinical practice: results of an international patterns of care survey within the framework of the ESTRO-EORTC E$^{2}$-RADIatE platform
46. In reply to letter to the editor: radiomic feature analysis of pre-treatment FDG PET-CT for predicting outcome in anal squamous cell carcinoma
47. Toxicity Prediction in Pelvic Radiotherapy Using Multiple Instance Learning and Cascaded Attention Layers
48. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study
49. A systematic review of clinical studies on variable proton Relative Biological Effectiveness (RBE)
50. Long-Term Results of a Randomized Trial in Locally Advanced Rectal Cancer: No Benefit From Adding a Brachytherapy Boost
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.